ULCERATIVE COLITIS (UC)
Clinical trials for ULCERATIVE COLITIS (UC) explained in plain language.
Never miss a new study
Get alerted when new ULCERATIVE COLITIS (UC) trials appear
Sign up with your email to follow new studies for ULCERATIVE COLITIS (UC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for ulcerative colitis: Long-Term drug test shows promise
Disease control OngoingThis study tests the long-term safety and effectiveness of upadacitinib (RINVOQ) in about 950 people with ulcerative colitis who didn't respond well to earlier treatment. Participants take the drug or a placebo orally. The goal is to see if it can control the disease over time wi…
Matched conditions: ULCERATIVE COLITIS (UC)
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 22, 2026 11:58 UTC
-
New drug aims to keep ulcerative colitis in remission
Disease control OngoingThis phase 3 study tests whether risankizumab, an injected drug, can safely maintain remission in people with ulcerative colitis who already improved with the same drug. Over 1,200 participants will receive either risankizumab or a placebo for 52 weeks, with an option to continue…
Matched conditions: ULCERATIVE COLITIS (UC)
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 22, 2026 11:57 UTC
-
New study probes daily life with IBD
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand how inflammatory bowel disease (IBD) affects patients' quality of life. Researchers will survey 385 adults with Crohn's disease or ulcerative colitis about their symptoms, emotional well-being, and social support. The goal is to identify factors that…
Matched conditions: ULCERATIVE COLITIS (UC)
Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:58 UTC